sur CARMAT (EPA:ALCAR)
CARMAT makes its first sales of artificial hearts in Israel
CARMAT announces that it has carried out the first commercial implantations of its Aeson® artificial heart outside the European Union. Two devices were recently implanted in Israel.
The first procedure took place at Hadassah Hospital Ein Kerem in Jerusalem, led by Prof. Offer Amir among other specialists. The second implantation took place at Sheba Medical Center in Tel Aviv, led by Dr. Jeff Morgan and his team.
CARMAT is thus expanding its international presence, bringing to five the number of countries where commercial establishments have been established, thus illustrating the growing interest in this therapeutic alternative.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de CARMAT